Expression of toll-like receptors on breast tumors: taking a toll on tumor microenvironment

Debika Bhattacharya1, Nabiha Yusuf

  • 1Department of Dermatology and Skin Diseases Research Center, University of Alabama at Birmingham, 1670 University Boulvard, VH 566A, P.O. Box 202, Birmingham, AL 35294-0009, USA.

Insights

Toll-like receptors (TLRs) expressed on breast cancer cells and inflammatory cells promote tumor growth and inflammation. Targeting these TLRs offers a promising new avenue for effective breast cancer treatment strategies.

Area of Science:

  • Oncology
  • Immunology

Background:

  • Breast cancer is a leading cause of mortality in women globally.
  • Toll-like receptors (TLRs) are implicated in cancer initiation and progression.
  • Inflammation is closely linked to cancer development, promoting angiogenesis, metastasis, and immune evasion.

Purpose of the Study:

  • To investigate the role of Toll-like receptors (TLRs) in breast cancer development and inflammation.
  • To explore the expression of various TLRs in mammary tumors and their impact on the tumor microenvironment.
  • To identify TLRs as potential therapeutic targets for breast cancer treatment.

Main Methods:

  • The study delineates the expression patterns of various Toll-like receptors (TLRs).
  • Mechanisms of TLR signaling in breast cancer cells and inflammatory cells were examined.
  • The impact of TLRs on tumor growth, survival, and metastatic progression was investigated.

Main Results:

  • Toll-like receptors (TLRs) are expressed on breast cancer cells and inflammatory cells within the tumor microenvironment.
  • TLR expression promotes inflammation, cell survival, angiogenesis, and metastasis.
  • TLR signaling contributes to tumor immune escape and progression.

Conclusions:

  • Toll-like receptors (TLRs) play a significant role in promoting inflammation and the development of mammary tumors.
  • Understanding TLR mechanisms in breast cancer offers potential therapeutic strategies.
  • Targeting TLRs on tumor and inflammatory cells presents a promising approach for breast cancer therapy.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...